Effects of Horticultural Therapy on Asian Elderly' Mental Health
HTRCT
1 other identifier
interventional
69
1 country
1
Brief Summary
The objective of this study is to determine whether horticultural therapy would improve the psychological well-being of the older adults. 70 healthy elderly were randomized into the active horticultural therapy or the waitlist control group. Sessions will be conducted weekly for 12 weeks, and monthly for 3 months. Participants would be assessed at 3 time-points: at the start, at 3-months and at 6-months. It was hypothesized that as compared to the waitlist control group, participants in the active horticultural therapy will have (1) lower depression and anxiety symptomatology; (2) higher life satisfaction; (3) feel more socially connected; and (4) improved cognitive functioning.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2015
CompletedFirst Submitted
Initial submission to the registry
June 24, 2015
CompletedFirst Posted
Study publicly available on registry
July 13, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2016
CompletedMay 9, 2016
May 1, 2016
6 months
June 24, 2015
May 6, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (11)
Change from baseline Zung Self-Rating Depression Scale (SDS) at 3-months and 6-months
The SDS (Zung, 1965) is a 20-item quantitative measurement of symptoms of depression. Participants rate each item regarding how they felt during the week preceding using a 4-point scale that ranges from 1 (a little of the time) to 4 (most of the time). A total raw score computed by summing the scores on the individual items will be converted into a percentage (the SDS index); the higher the SDS index, the greater the severity of depressive symptoms. Several studies have established the SDS as a reliable and valid instrument for measuring depressive symptoms (Biggs et al., 1978; Gabrys and Peters, 1985; Agrell and Dehlin, 1989).
baseline, 3-months, 6-months
Change from baseline Zung Self-Rating Anxiety Scale (SAS) at 3-months and 6-months
The SAS (Zung, 1971) will be used to measure anxiety of the participants in the preceding week. It is a 20-item self-report assessment designed to measure anxiety levels, based on cognitive, autonomic, motor and central nervous system symptoms. Each question is scored on a Likert-type scale of 1-4 (a little of the time) to (most of the time). Some questions are negatively worded to avoid the problem of set response. Overall assessment is done by total score. The total raw scores range from 20-80. The raw score then needs to be converted to an "Anxiety Index" score; the higher the SAS index, the greater the severity of depressive symptoms.
baseline, 3-months, 6-months
Change from baseline Ryff's Scales of Psychological Well-being at 3-months and 6-months
The Ryff Scales of Psychological Well-Being (Ryff and Singer, 1998) is an 18-item questionnaire which reflects the six areas of psychological well-being: autonomy, environmental mastery, personal growth, positive relations with others, purpose in life, and self-acceptance. Respondents rate statements on a scale of 1 to 6, with 1 indicating strong disagreement and 6 indicating strong agreement.
baseline, 3-months, 6-months
Change from baseline Satisfaction with Life Scale (SWLS) at 3-months and 6-months
Satisfaction with Life Scale (SWLS; Diener, Emmons, Larsen and Griffin, 1985) will be administered. SWLS is a 5-item scale designed to measure global cognitive judgments of one's life satisfaction (not a measure of either positive or negative affect). It is a psychometrically sound measure (Larson, Diener and Emmons, 1985) and has been validated in a geriatric population (Diener et al., 1985). Participants indicate how much they agree or disagree with each of the 5 items using a 7-point scale that ranges from 1 (strongly disagree) to 7 (strongly agree). Total scores were computed by summing the scores on the individual items and ranged from 5 to 35, with higher scores indicating higher level of satisfaction with life.
baseline, 3-months, 6-months
Change from baseline Friendship Scale (FS) at 3-months and 6-months
Social connectedness scale will be measured using the Friendship Scale (Hawthorne, 2006). It is a 6-item questionnaire that measures both social isolation and social connectedness. Participants were asked to rate the frequency in which each statement describes them during the past four weeks on a 5-point Likert scale ranging from 0 (almost always) to 5 (not at all). Total scores were computed by summing the scores on the individual items and ranged from 0 to 24, with higher scores indicating higher level of social connectedness. The Friendship Scale was developed as a short, user-friendly, stand alone scale measuring perceived social isolation. It was validated with older adults with excellent internal structures, reliability and validity (Hawthorne, 2006; Hawthorne, 2008).
baseline, 3-months, 6-months
Change from baseline Interleukin 6 (IL-6) at 3-months and 6-months
10ml of fasting blood will be collected using CPT tube
baseline, 3-months, 6-months
Change from baseline Interleukin-1 beta (IL-1β) at 3-months and 6-months
10ml of fasting blood will be collected using CPT tube
baseline, 3-months, 6-months
Change from baseline C-reactive protein (CRP) at 3-months and 6-months
10ml of fasting blood will be collected using CPT tube
baseline, 3-months, 6-months
Change from baseline Cortisol at 3-months and 6-months
10ml of fasting blood will be collected using CPT tube
baseline, 3-months, 6-months
Change from baseline Brain-derived neurotrophic factor (BDNF) at 3-months and 6-months
10ml of fasting blood will be collected using CPT tube
baseline, 3-months, 6-months
Change from baseline Dehydroepiandrosterone sulphate (DHEAS) at 3-months and 6-months
10ml of fasting blood will be collected using CPT tube
baseline, 3-months, 6-months
Secondary Outcomes (8)
Change from baseline Montreal Cognitive Assessment (MoCA) at 3-months and 6-months
baseline, 3-months, 6-months
Change from baseline Clinical Dementia Rating (CDR) at 3-months and 6-months
baseline, 3-months, 6-months
Change from baseline Rey Auditory Verbal Learning Test (RAVLT) at 3-months and 6-months
baseline, 3-months, 6-months
Change from baseline Digit Span Task at 3-months and 6-months
baseline, 3-months, 6-months
Change from baseline Colour Trails Tests (CTT) at 3-months and 6-months
baseline, 3-months, 6-months
- +3 more secondary outcomes
Other Outcomes (2)
Demographic questionnaire
Baseline
Feedback questionnaire
Baseline
Study Arms (2)
Active Horticultural Therapy
EXPERIMENTAL15 sessions of Horticultural Therapy program teaching the elderly about gardening techniques and for them to benefit from the therapeutic effects of the parks
Waitlist Control Group
OTHERParticipants will receive the same horticultural therapy program at the end of the assessments
Interventions
The Horticultural Therapy intervention consists of 1 hour sessions weekly for first 3 months, followed by monthly session for the next 3 months. They will be taught on the basic gardening techniques such as sowing, weeding and fertilization during the hands-on sessions. They will also be taken on walks to the various parks to enjoy the therapeutic effect of the park greenery
Eligibility Criteria
You may qualify if:
- Community-living elderly aged between 60 to 85 years AND
- able to provide informed consent AND
- function independently AND
- With a minimum score of 22 and above on the Montreal Cognitive Assessment.
You may not qualify if:
- Does not have a minimum score of 22 and above on the Montreal Cognitive Assessment OR
- Currently suffering from or have history of severe medical conditions e.g. cancer, stroke, Parkinson disease OR
- History of severe psychiatric conditions e.g. schizophrenia, bipolar disorder OR
- Dementia OR
- Undergoing another therapy at the same time OR
- Significant visual or hearing impairment OR
- Marked upper and lower limb motor difficulties, which may affect their ability to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National University of Singaporelead
- National Parks Board, Singaporecollaborator
Study Sites (1)
Training and Research Academy; Jurong Point Shopping Centre
Singapore, Singapore, 460077, Singapore
Related Publications (36)
Aydemir C, Yalcin ES, Aksaray S, Kisa C, Yildirim SG, Uzbay T, Goka E. Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women. Prog Neuropsychopharmacol Biol Psychiatry. 2006 Sep 30;30(7):1256-60. doi: 10.1016/j.pnpbp.2006.03.025. Epub 2006 May 2.
PMID: 16647794BACKGROUNDBarnicle, T., & Midden, K. S. (2003). The effects of a horticulture activity program on the psychological well-being of older people in a long-term care facility. HortTechnology, 13(1), 81-85.
BACKGROUNDBaune BT, Smith E, Reppermund S, Air T, Samaras K, Lux O, Brodaty H, Sachdev P, Trollor JN. Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: the prospective Sydney Memory and Aging Study. Psychoneuroendocrinology. 2012 Sep;37(9):1521-30. doi: 10.1016/j.psyneuen.2012.02.006. Epub 2012 Mar 9.
PMID: 22406002BACKGROUNDBOARD F, PERSKY H, HAMBURG DA. Psychological stress and endocrine functions; blood levels of adrenocortical and thyroid hormones in acutely disturbed patients. Psychosom Med. 1956 Jul-Aug;18(4):324-33. doi: 10.1097/00006842-195607000-00006. No abstract available.
PMID: 13350458BACKGROUNDBrunoni AR, Lopes M, Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol. 2008 Dec;11(8):1169-80. doi: 10.1017/S1461145708009309. Epub 2008 Aug 28.
PMID: 18752720BACKGROUNDChu, C. M., & Simpson, R. (1994). Ecological public health: from vision to practice. Centre for Health Promotion, University of Toronto: ParticipACTION.
BACKGROUNDDowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctot KL. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010 Mar 1;67(5):446-57. doi: 10.1016/j.biopsych.2009.09.033. Epub 2009 Dec 16.
PMID: 20015486BACKGROUNDGervasoni N, Aubry JM, Bondolfi G, Osiek C, Schwald M, Bertschy G, Karege F. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology. 2005;51(4):234-8. doi: 10.1159/000085725. Epub 2005 May 12.
PMID: 15897674BACKGROUNDGIBBONS JL. CORTISOL SECRETION RATE IN DEPRESSIVE ILLNESS. Arch Gen Psychiatry. 1964 Jun;10:572-5. doi: 10.1001/archpsyc.1964.01720240026004. No abstract available.
PMID: 14159257BACKGROUNDGIBBONS JL, McHUGH PR. Plasma cortisol in depressive illness. J Psychiatr Res. 1962 Sep;1:162-71. doi: 10.1016/0022-3956(62)90006-7. No abstract available.
PMID: 13947658BACKGROUNDGonzalez MT, Hartig T, Patil GG, Martinsen EW, Kirkevold M. A prospective study of existential issues in therapeutic horticulture for clinical depression. Issues Ment Health Nurs. 2011;32(1):73-81. doi: 10.3109/01612840.2010.528168.
PMID: 21208054BACKGROUNDGonzalez MT, Hartig T, Patil GG, Martinsen EW, Kirkevold M. Therapeutic horticulture in clinical depression: a prospective study of active components. J Adv Nurs. 2010 Sep;66(9):2002-13. doi: 10.1111/j.1365-2648.2010.05383.x. Epub 2010 Jul 2.
PMID: 20626473BACKGROUNDGrahn, P., & Stigsdotter, U. A. (2003). Landscape planning and stress. Urban forestry & urban greening, 2(1), 1-18.
BACKGROUNDHancock, T. (1999). Health care reform and reform for health: creating a health system for communities in the 21st century. Futures, 31(5), 417-436.
BACKGROUNDHartig, T., Evans, G. W., Jamner, L. D., Davis, D. S., & Gärling, T. (2003). Tracking restoration in natural and urban field settings. Journal of environmental psychology, 23(2), 109-123.
BACKGROUNDHayashi, N., Wada, T., Hirai, H., Miyake, T., Matsuura, Y., Shimizu, N., Kurooka, H. & Horiuchi, S. (2008). The effects of horticultural activity in a community garden on mood changes. Environmental Control in Biology, 46(4), 233-240.
BACKGROUNDHenrich J, Heine SJ, Norenzayan A. Most people are not WEIRD. Nature. 2010 Jul 1;466(7302):29. doi: 10.1038/466029a. No abstract available.
PMID: 20595995BACKGROUNDHiles SA, Baker AL, de Malmanche T, Attia J. A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: exploring the causes of heterogeneity. Brain Behav Immun. 2012 Oct;26(7):1180-8. doi: 10.1016/j.bbi.2012.06.001. Epub 2012 Jun 9.
PMID: 22687336BACKGROUNDHowren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med. 2009 Feb;71(2):171-86. doi: 10.1097/PSY.0b013e3181907c1b. Epub 2009 Feb 2.
PMID: 19188531BACKGROUNDJeste DV, Alexopoulos GS, Bartels SJ, Cummings JL, Gallo JJ, Gottlieb GL, Halpain MC, Palmer BW, Patterson TL, Reynolds CF 3rd, Lebowitz BD. Consensus statement on the upcoming crisis in geriatric mental health: research agenda for the next 2 decades. Arch Gen Psychiatry. 1999 Sep;56(9):848-53. doi: 10.1001/archpsyc.56.9.848.
PMID: 12884891BACKGROUNDKam, M. C., & Siu, A. M. (2010). Evaluation of a horticultural activity programme for persons with psychiatric illness. Hong Kong Journal of Occupational Therapy, 20(2), 80-86.
BACKGROUNDKamioka H, Tsutani K, Yamada M, Park H, Okuizumi H, Honda T, Okada S, Park SJ, Kitayuguchi J, Abe T, Handa S, Mutoh Y. Effectiveness of horticultural therapy: a systematic review of randomized controlled trials. Complement Ther Med. 2014 Oct;22(5):930-43. doi: 10.1016/j.ctim.2014.08.009. Epub 2014 Sep 1.
PMID: 25440385BACKGROUNDKarege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 2002 Mar 15;109(2):143-8. doi: 10.1016/s0165-1781(02)00005-7.
PMID: 11927139BACKGROUNDKim YK, Lee HP, Won SD, Park EY, Lee HY, Lee BH, Lee SW, Yoon D, Han C, Kim DJ, Choi SH. Low plasma BDNF is associated with suicidal behavior in major depression. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):78-85. doi: 10.1016/j.pnpbp.2006.06.024. Epub 2006 Aug 10.
PMID: 16904252BACKGROUNDLee BH, Kim H, Park SH, Kim YK. Decreased plasma BDNF level in depressive patients. J Affect Disord. 2007 Aug;101(1-3):239-44. doi: 10.1016/j.jad.2006.11.005. Epub 2006 Dec 13.
PMID: 17173978BACKGROUNDKua EH. A community study of mental disorders in elderly Singaporean Chinese using the GMS-AGECAT package. Aust N Z J Psychiatry. 1992 Sep;26(3):502-6. doi: 10.3109/00048679209072077.
PMID: 1417639BACKGROUNDKua E.H., Ko, S.M., Fones, C.S.L., & Tan S.L. (1997a). Epidemiology of depression in elderly Chinese living in Singapore. Journal of American Medical Association (Suppl), 13: 29-32.
BACKGROUNDLiu Y, Ho RC, Mak A. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression. J Affect Disord. 2012 Aug;139(3):230-9. doi: 10.1016/j.jad.2011.08.003. Epub 2011 Aug 26.
PMID: 21872339BACKGROUNDMilligan C, Gatrell A, Bingley A. "Cultivating health": therapeutic landscapes and older people in northern England. Soc Sci Med. 2004 May;58(9):1781-93. doi: 10.1016/S0277-9536(03)00397-6.
PMID: 14990378BACKGROUNDOwen BM, Eccleston D, Ferrier IN, Young AH. Raised levels of plasma interleukin-1beta in major and postviral depression. Acta Psychiatr Scand. 2001 Mar;103(3):226-8. doi: 10.1034/j.1600-0447.2001.00162.x.
PMID: 11240580BACKGROUNDSen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry. 2008 Sep 15;64(6):527-32. doi: 10.1016/j.biopsych.2008.05.005. Epub 2008 Jun 24.
PMID: 18571629BACKGROUNDShimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, Nakazato M, Watanabe H, Shinoda N, Okada S, Iyo M. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry. 2003 Jul 1;54(1):70-5. doi: 10.1016/s0006-3223(03)00181-1.
PMID: 12842310BACKGROUNDThomas AJ, Davis S, Morris C, Jackson E, Harrison R, O'Brien JT. Increase in interleukin-1beta in late-life depression. Am J Psychiatry. 2005 Jan;162(1):175-7. doi: 10.1176/appi.ajp.162.1.175.
PMID: 15625217BACKGROUNDTse MM. Therapeutic effects of an indoor gardening programme for older people living in nursing homes. J Clin Nurs. 2010 Apr;19(7-8):949-58. doi: 10.1111/j.1365-2702.2009.02803.x.
PMID: 20492039BACKGROUNDValkanova V, Ebmeier KP, Allan CL. CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disord. 2013 Sep 25;150(3):736-44. doi: 10.1016/j.jad.2013.06.004. Epub 2013 Jul 17.
PMID: 23870425BACKGROUNDChan HY, Ho RC, Mahendran R, Ng KS, Tam WW, Rawtaer I, Tan CH, Larbi A, Feng L, Sia A, Ng MK, Gan GL, Kua EH. Effects of horticultural therapy on elderly' health: protocol of a randomized controlled trial. BMC Geriatr. 2017 Aug 29;17(1):192. doi: 10.1186/s12877-017-0588-z.
PMID: 28851276DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Roger CM Ho, FRCP
National University of Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant Psychiatrist
Study Record Dates
First Submitted
June 24, 2015
First Posted
July 13, 2015
Study Start
April 1, 2015
Primary Completion
October 1, 2015
Study Completion
October 1, 2016
Last Updated
May 9, 2016
Record last verified: 2016-05